Notably, a selective MAG loss is spotted in the lesion formation in several neurodegenerative diseases including Kearns-Sayre syndrome (Lax et al., 2012) and MS (Aboul-Enein et al., 2003). This evidence concerns the gene MAG and myeloid sarcoma.